ARIA: A Phase 1b/2, Open-label, Multi Cohort Trial of Tazemetostat in Combination With Various Treatments in Subjects With Relapsed or Refractory Hematologic Malignancies

Condition: Follicular Lymphoma, Diffuse Large B Cell Lymphoma


Go To Trial Homepage